Safety and Immunogenicity of EXG-5003
Clinical trial NCT04863131 · COMPLETED
Trial details
- NCT number
- NCT04863131
- Sponsor
- Fujita Health University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2022-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.